Using Conjoint Analysis to Elicit Benefit–Risk Preferences for Different Treatment Options Among Psoriasis Patients Receiving Systemic Therapy
Background: Psoriasis has a huge impact on a patient’s life. Treatment dissatisfaction and non-adherence are common among patients with psoriasis, partly due to discordance between individual preferences and recommended treatments. The modern strategy for psoriasis should be focused on human-centric treatment that recognizes the needs and preferences of patients with a goal for safe, effective, quality and acceptable health services for a lifetime. The aim of this analysis was to capture patients’ preferences with moderate-to-severe psoriasis regarding various treatment attributes. Methods: A specialized questionnaire containing four attributes with three levels, each, was used, followed by an orthogonal plan based on conjoint analysis. Nine combinations of therapeutic scenarios were produced as a result, to investigate participants’ preferences. Respondents were asked to rank alternatives from best to worst. Results: The risk of developing pneumonia or other serious infections within a decade seems to be higher in patients with an implied assigned value of 37. The second attribute was the type and frequency of the administration with a value of 27, followed by the treatment effectiveness with great improvement of body surface with a value of 25. The lowest utility (11) was the sustainability of early remission of psoriasis. Conclusions: Psoriasis patients want safe, effective and easy to administer treatments.
Authors
- Konstantinos Sfaelos (ORCID: https://orcid.org/0000-0001-7645-7187)
- Eleftheria Tampouratzi (ORCID: https://orcid.org/0000-0002-3025-5085)
- Antonios Tsartsarakis
- Vassilis Aletras (ORCID: https://orcid.org/0000-0002-3367-7777)
- Christos Moulias
Institutions
- University of Macedonia (GR)
- University of Ioannina (GR)
- General Hospital of Serres (GR)
- Tzaneion General Hospital (GR)
- University Hospital of Ioannina (GR)
Publication Details
- Journal
- Therapeutics
- Published
- 2025-10-31
- DOI
- https://doi.org/10.3390/therapeutics2040019
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00